<DOC>
	<DOCNO>NCT01307488</DOCNO>
	<brief_summary>A switch regimen consist ATV/RTV 300/100 mg QD + 3TC 300 mg QD HIV-1 infected subject first antiretroviral regimen virologically suppress regimen consist 2 NRTIs + 3rd agent , non-inferior continue switch ATV/RTV 300/100 mg QD + 2 optimized NRTIs maintenance virological suppression .</brief_summary>
	<brief_title>Simplification Atazanavir/Ritonavir + Lamivudine Maintenance Therapy</brief_title>
	<detailed_description>Clinical Trial , phase IV , randomize , open label , multicenter approve drug use condition . A switch regimen consist ATV/RTV 300/100 mg QD + 3TC 300 mg QD HIV-1 infected subject first antiretroviral regimen virologically suppress regimen consist 2 NRTIs + 3rd agent , non-inferior continue switch ATV/RTV 300/100 mg QD + 2 optimized NRTIs maintenance virological suppression .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<criteria>Signature inform consent At least 18 year old Patients 1st ARV treatment consist 2 NRTIs + 1 third agent least 1 year Undetectable viral load least 6 month prior inclusion study ( VL &lt; 50 c/mL 2 determination 6 month apart ; blip allow ) . Requirement ARV treatment change due toxicity , intolerance simplification . Clinically stable . Pregnant woman woman plan get pregnant study . Breast feeding History change ARV treatment component reason 4 month prior inclusion trial History ARV treatment change due virological failure History confirm virological failure define one single VL &gt; 400 c/mL least 2 VL 50 400 c/mL one year indetectable VL achieve . Absence HIV genotype prior ARV treatment initiation . Resistance mutation study drug ( ATV , RTV , 3TC ) HBV infection . History toxicity intolerance ATV , RTV 3TC . Gilbert 's syndrome . Use contraindicate drug . Lab abnormality grade 4 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>HIV</keyword>
	<keyword>AIDS</keyword>
	<keyword>Atazanavir</keyword>
	<keyword>Simplification</keyword>
</DOC>